GROUP ONE TRADING, L.P. - DIAMEDICA THERAPEUTICS INC ownership

DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 42 filers reported holding DIAMEDICA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 7.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of DIAMEDICA THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$0
-100.0%
20
-99.9%
0.00%
Q4 2021$126,000
+29.9%
33,868
+39.8%
0.00%
Q3 2021$97,000
+470.6%
24,218
+550.7%
0.00%
Q2 2021$17,0003,7220.00%
Other shareholders
DIAMEDICA THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Manatuck Hill Partners, LLC 272,400$564,0000.31%
Worth Venture Partners, LLC 141,801$294,0000.17%
Granite Point Capital Management, L.P. 227,230$470,0000.07%
Stonepine Capital Management, LLC 13,705$28,0000.03%
WEXFORD CAPITAL LP 88,860$184,0000.03%
Patriot Financial Group Insurance Agency, LLC 2,000$4,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 15,399$31,0000.00%
MILLENNIUM MANAGEMENT LLC 70,919$145,0000.00%
TORONTO DOMINION BANK 24$00.00%
BANK OF MONTREAL /CAN/ 310$1,0000.00%
View complete list of DIAMEDICA THERAPEUTICS INC shareholders